Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
| Last modified: | 01 July 2020 1.31 p.m. |
More news
-
03 April 2025
IMChip and MimeCure in top 10 of the national Academic Startup Competition
Prof. Tamalika Banerjee’s startup IMChip and Prof. Erik Frijlink and Dr. Luke van der Koog’s startup MimeCure have made it into the top 10 of the national Academic Startup Competition.
-
01 April 2025
NSC’s electoral reform plan may have unwanted consequences
The new voting system, proposed by minister Uitermark, could jeopardize the fundamental principle of proportional representation, says Davide Grossi, Professor of Collective Decision Making and Computation at the University of Groningen
-
01 April 2025
'Diversity leads to better science'
In addition to her biological research on ageing, Hannah Dugdale also studies disparities relating to diversity in science. Thanks to the latter, she is one of the two 2024 laureates of the Athena Award, an NWO prize for successful and inspiring...